In case you haven’t heard, there’s a little pink pill that allegedly can increase a woman’s libido. Known as “flibanserin,” the drug is owned by Sprout Pharmaceuticals. It was twice rejected by the FDA, according to the New York Times, “on the grounds that its very modest effectiveness was outweighed by side effects like sleepiness, dizziness and nausea.”

But now Sprout Pharmaceuticals is being joined by the National Council of Women’s Organizations, the Black Women’s Health Imperative, Jewish Women International and some medical groups like the Association of Reproductive Health Professionals in a campaign called “Even the Score” to urge the FDA to approve the drug. The campaign charges that FDA is engaging in gender bias for approving Viagra and 25 other drugs to help men have sex, but none for women.

They even created a spoof of a typical Viagra commerce to help hammer home their point:

1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

Comments

comments